Hello All,
First, I am 100% along the lines of @Amanda. I said just last week that for me I was working on everything outside of NRx and that the EUA would just be a bonus.
However, like everyone I read various sources and from what I have read here and elsewhere since last night news, I have these troubling questions :
1. Dr J has on his CV having worked at the FDA, yet he now has 2 failures, both of the same type : insufficient numbers or data, but mainly numbers of patients. No-one knows what Relief will do but I would not use him ever again to do work for my firm, and that is not taking into account the lawsuit and everything else he has done. Terms like "lazy", and "sloppy" come to mind but, perhaps worse, is how at this level can anyone make the same mistake twice, and a fundamental mistake at that : numbers, just numbers. If this was one of our contractors and I had ruled out "lazy" and "sloppy", I would be thinking "inability to scale up" and that means one or both of two things : using money incorrectly/wastefully, or the person does not have the management capability to properly scale up. Either option is no good.
2. I also saw a post where someone was troubled by the discrepancy between the figure quoted by the FDA, 131 patients, versus the one quoted in all NRx communications, 144. I did not quite catch on initially but I believe the poster is hinting at misinformation from NRx on the actual samples passed on to the FDA. If this proves correct then that is even worse than (1) above.
3. It will be interesting to see what the Market Makers do today. While many NRx investors will sell I am not so sure about Relief investors. I won't and by the sentiments of most I have seen on this board in the last 24 hours, it looks like most of us were no longer counting on the EUA anyway, and I certainly cannot see any institution selling. But where I am going with this is that, the silver lining on our non-EUA is that it gives Relief a massive advantage now in their negotiations with NRx as part of the court case : he has failed twice, returned ZERO, he is in an even worse place to be able to negotiate anything as far as I can see, so it will be interesting how that plays out and whether Market Makers cushion the drop because of that aspect.
With all the above in play, it will be interesting to see how it all moves because I fail to see an involvement of NRx in our future : fails twice in the same way and even tried to defraud us at the same time. Really !!!
Interesting next week or two.
~ IlkaS, Y@h00 RLFTF finance conversations
